Abstract
Immune checkpoint inhibitors (ICI) based on anti-CTLA-4 (alpha CTLA-4) and anti-PD1 (alpha PD1) are being tested in combination with different therape......
小提示:本篇文献需要登录阅读全文,点击跳转登录